P719: RANDOMIZED PHASE 1-2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS: INTERIM SAFETY ANALYSIS
P719:评估低剂量(LD)口服地西他滨/西达扎利定(ASTX727)治疗低危骨髓增生异常综合征(LR-MDS)患者的安全性和有效性的随机1/2期研究:中期安全性分析
期刊:Jnci-Journal of the National Cancer Institute
影响因子:7.2
doi:10.1093/jnci/djac211
Pederson, Holly J; Faubion, Stephanie S; Pruthi, Sandhya; Goldfarb, Shari; Garcia-Manero, Guillermo; Bachishvili, Kimo; A. Griffiths, Elizabeth; M. Zeidan, Amer; Traer, Elie; Saini, Lalit; Amin, Harshad; Mohan, Sanjay; Lübbert, Michael; Maness-Harris, Lori; M Foran, James; Selleslag, Dominik; Xicoy Cirici, Blanca; Aaron Pollyea, Daniel; Sallman, David; Al-Kali, Aref; Berdeja, Jesus; Kathrin Al-Ali, Haifa; Y Zhu, Nancy; Font Lopez, Patricia; Sanz Santillana, Guillermo; Santini, Valeria; A. Yimer, Habte; D Cripe, Larry; Priego, Victor; Odenike, Olatoyosi; Heyrman, Bert; Valcarcel, David; Vachhani, Pankit; Sano, Yuri; Mirakhur, Beloo; Oganesian, Aram; Keer, Harold; Yacoub, Abdulraheem